1. HBW Insight
  2. >>Geography

Hatch Questions FDA Motive, Process In Proposed Vinpocetine Ban

 
• By Malcolm Spicer

Hatch, primary author of the legislation Congress passed in 1994 as FDA's framework for regulating the supplement industry, notes in a letter that FDA did not question vinpocetine's safety in evaluations of five NDI notifications.

The dietary supplement industry's strongest Capitol Hill ally says FDA's proposal to ban the ingredient vinpocetine bucks the agency's policies, ignores the potential economic impact and "could shake the confidence" of manufacturers.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America